Chemistry, Manufacturing, and Controls Development and Readiness Pilot Program (CDRP)
Similar Posts
What’s New in Regulatory Science
A newsletter on regulatory science for CDER’s stakeholdersCDER SBIA Chronicles
FDA/CDER SBIA Chronicles, the bi-monthly newsletter of the CDER Small Business and Industry Assistance team, provides industry with useful information to assist in all aspects of drug marketing and regulationStellalife, Inc. – 712804 – 09/16/2025
Unapproved New Drugs/MisbrandedQuestions and Answers on the iPLEDGE REMS
Questions and Answers on the iPLEDGE REMSFDA Approves Expanded Use of Vonvendi for von Willebrand Disease, Including for Certain Uses for Children
The U.S. Food and Drug Administration today approved expanded use of Vonvendi [von Willebrand factor (Recombinant)] for routine preventative (prophylactic) use in adults (age 18 years and older) with all types of von Willebrand disease (VWD) and on-demand and treatment of bleeding episodes and perioLaboratorios Farmeceuticos Rovi, SA – 5/19/2023
Laboratorios Farmeceuticos Rovi, SA – 5/19/2023. Country: Spain. Record Type: 483